how to avoid them What is the problem We have a reproducibility crisis in science The consequence is a enormous waste in materials time and money costing an estimated US350 million annually in the US alone ID: 784613
Download The PPT/PDF document "Blame it on the antibodies: the most com..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Blame it on the antibodies: the most common problems with antibodies and how to avoid them
What is the problem?
We have a reproducibility crisis in science. The consequence is a enormous waste in materials, time and money, costing an estimated
US$350 million
annually in the US alone!
‘Bad’ antibodies are considered part of the reproducibility crisis.
Slide2Blame it on the antibodies: the most common problems with antibodies and how to avoid them
What is a ‘bad’ antibody?
Slide3Blame it on the antibodies: the most common problems with antibodies and how to avoid them
A few examples (worth a read):
In a 2008 study (Berglund et al. 2008, Mol. Cell. Proteomics)
fewer than half of ~6.000
routinely used commercial antibodies
recognized only their specific targets!
In a 2009 study on 49 commercially available antibodies targeting 19 different GPCRs (Michel et al. 2009, Arch.
Pharmacol
.),
most bound to more than one target protein
!
In 2011, an evaluation of 246 antibodies used in epigenetic studies found that
one quarter failed tests for specificity
(
Egelhofer
et al. 2011, Nat. Struct. Mol. Biol.)!
Slide4Blame it on the antibodies: the most common problems with antibodies and how to avoid them
What is the cause of the ‘bad’ antibody problem?
Three decades ago scientists had to make and validate their antibodies themselves.
Today, more than 300 companies sell over 200 million antibodies: a market worth 1.6$ billion!
Commercially available antibodies are often only poorly validated for target specificity and lot-to-lot variability!
Different vendors provide different levels of validation, depending on their approach to the balance between profit making and high quality provision
Slide5Blame it on the antibodies: the most common problems with antibodies and how to avoid them
Berglund et al. 2008, Mol. Cell. Proteomics
Slide6Blame it on the antibodies: the most common problems with antibodies and how to avoid them
How should we validate an antibody?
Bordeaux et al. 2010, Biotechniques
‘Antibodies are not magic reagents. We can’t just throw them onto our sample and expect the result we get is 100% reliable without putting some critical thinking into it!’
Slide7Polyclonal vs. monoclonal antibodies
Polyclonal antibodies
-Purified from antiserum raised against antigen
-Heterogeneous mixture of different antibodies
Each Ab is a product of different plasma cellsAre immunologically different
React with various epitopes on the antigenLess sensitive to variations in sample preparations
Better for detection of low antigen levels/fast capture (IP)/denatured proteins (WB)Large amounts of non-specific antibodiesCross reactivity/background possible in some applicationsEasy and cheap to produceLimited quantities availableBatch-to-batch variations are common
Monoclonal antibodies
Product of an individual clone of plasma cellsAre immunologically identical and have uniform affinityReact with a specific epitope on the antigenAbsence of nonspecific antibodies/low background
Better choice for cell/tissue staining and flow sorting
Targeted epitope must survive fixation
Expensive to produce/cell culture required
Long timeframe for hybridoma production
Unlimited quantities available
No batch-to-batch variability
Slide8Blame it on the antibodies: the most common problems with antibodies and how to avoid them
How do we find a good antibody?
Know your biochemistry
Read, read, read: screen the available literature and the internet about the antigen of interest.
Which antibodies have already been used and validated in other studies?
Maybe someone has made an antibody themselves? (those are usually properly validated)
Browse databases:
https://www.antibodypedia.com/
,
http://www.proteinatlas.org/
,
Check out ‘reliable’ vendors that provide user-feedback reports and rankings,
e.g
Abcam
,
Cell Signalling Tech, St. John’s Labs.
Check out the ‘developmental studies hybridoma bank (DSHB,
http://dshb.biology.uiowa.edu/
)
for monoclonal antibodies.
Read the datasheet
: check if the antibody has been tested for the specific application
you need it for.
Slide9How to validate an antibody for western blotting?
Ackerl
et al. 2007, J. Cell Sci.
Walko et al. 2017, Nat.
Comms
®CST
Knock-down / knock-out negative controls
Positive controls (overexpression)
Activated/inhibitor-treated samples for signalling pathways
Slide10How to validate an antibody for immunofluorescence staining of cells?Walko et al. 2017, Nat.
Comms
®CST
AGR2
AGR2
®CST
NFkb
NFkb
Slide111:200
1:400
1:800
1:1.600
1:3.200
1:6.400
Antibody dilution for optimal results
α
Kindlin2 /
DAPI
Courtesy of E.
Rognoni
Slide12How to validate an antibody for immunofluorescence staining of tissues?
c
Rognoni
et al. 2014, Nat. Med.
Knock-down / knock-out negative controls
Slide13How to validate an antibody for immunofluorescence staining of tissues?
Lim et al. 2013, Science
Blocking peptides/proteins
Slide14How to validate an antibody for flow sorting?
HUVEC (CD102pos.)
HeLa (CD102neg.)
CREB Rabbit
mAb
Rabbit
mAb
IgG
®CST
Slide15FixationFixation is the preservation of cells and tissues in a reproducible and lifelike manner
What is it use for?
Fixatives stabilize the cells and tissues
Fixatives prevent autolysis by inactivating lysosomal enzymes and inhibit growth of bacteria
Fixation breaks down cell barrier and allows relatively large molecules to penetrate
Problems?
Fixatives denature proteins by coagulation, by forming additive compounds or by a combination of the two
The resulting complexes differ from the undenatured proteins in both chemical and antigenic profiles
Fixation is always a compromise
Slide16PFA 1%
α
Kindlin1 /
DAPI
αPaxillin/ DAPI
Overlay
Courtesy of E. Rognoni
Slide17MeOH:Acetone
α
Kindlin1 /
DAPI
αPaxillin
/ DAPI
Overlay
Courtesy of E.
Rognoni
Slide18Formaldehyde-based fixativesPositive:
Fixatives are well tolerated by tissues and have good penetration
Formaldehyde reacts primarily with basic amino groups to form cross-linking “methylene bridges”
Formaldehydes do not permeabilize cells/tissues
Negative:
Antigen masking is very common
Proteolytic enzyme digestion and/or antigen retrieval often necessary
Slide19Methanol and acetoneSimultaneous fixation and permeabilization
Remove lipids from the plasma membrane and coagulate (precipitate) the proteins
Positive:
Permit good antibody penetration
Often excellent preservation of antigens
Proteolytic digestion or antigen retrieval are not required
Negative:
Penetration in tissue is very poor
Fixation is often not completeSometimes the localization of soluble proteins is disrupted
Slide20Paraffin or Frozen sections?
Morphology is better preserved
Better retention of labile proteins, nucleic acids and small peptides
Fixation and embedding cause antigen masking
Some epitopes do not survive fixation and embedding.
Enzymatic- or heat- mediated antigen retrieval must be used
Antigen preservation is better
Preparation is faster
Selection of different and optimal fixative for each antigen possible all from the same block
Morphological detail and resolution of the frozen sections is usually inferior
Frozen sections are less stable
Paraffin section Frozen section
+
-
+
-
+
-
+
-
-
+